Table 1. Baseline patient characteristics.
Characteristic | Value |
---|---|
Median age in years [range] | 58 [34–69] |
Gender (male/female) | 26/4 |
Status (alive/dead) | 24/6 |
PD-L1 expression: +/−/NA | 10/13/7 |
Targeted deep sequencing | 30 |
Smoker or ex-smoker/non-smoker | 7/23 |
Never-drinker/ever drinker | 18/12 |
Hepatitis (positive/never) | 24/6 |
CCLC stage (Ia/Ib/IIa/IIb/IIIa) | 10/7/7/1/4 |
BCLC stage (A/B) | 12/17 |
Tumor number (1/2–3/over 3) | 19/5/4 |
Tumor location (SF/C/DC/HF/R) | 10/4/5/8/3 |
Median (range) tumor size, cm | 5.5 (1.7–13) |
Microvascular invasion (yes/no) | 12/18 |
α-fetoprotein (AFP) >20 μg/L | 17 |
NA, not available; SF, sigmoid flexure; C, cecum; DC, descending colon; HF, hepatic flexure; R, rectum.